“Today marks a incredible milestone for Bausch + Lomb and an critical move forward on the path to an unbiased organization concentrated on eye wellbeing,” explained Joseph Papa, chairman and CEO, Bausch + Lomb. “Bausch + Lomb has prolonged been associated with many of the most substantial developments in eye health, and I am honored to work together with our 12,000 world wide personnel as we go on to concentration on attaining our ongoing mission of supporting men and women see far better to live much better all in excess of the globe.”
As a completely integrated eye overall health organization, Bausch + Lomb delivers a in depth portfolio of additional than 400 solutions spanning get hold of lenses, lens and eye care products and solutions, ophthalmic prescription drugs, about-the-counter goods and ophthalmic surgical products and instruments. Because its founding in 1853, Bausch + Lomb has been committed to advancing eye health and fitness for people today all in excess of the environment, and has pioneered hundreds of improvements, which includes SofLens, the 1st mass-manufactured comfortable make contact with lens. Bausch + Lomb’s recent portfolio features market-top goods, this kind of as Biotrue and renu multi-purpose methods, Biotrue ONEday every day disposable make contact with lenses, LUMIFY redness reliever eye drops, PreserVision AREDS 2 system eye vitamin and mineral supplements and VYZULTA (latanoprostene bunod ophthalmic solution), .024%.
“Over the course of our company’s nearly two century very long historical past, Bausch + Lomb has constantly stood at the forefront of cutting-edge scientific and technological optical breakthroughs, and today is no distinct. We are much more focused than at any time on establishing and providing new treatment plans to meet up with unmet eye wellness demands,” ongoing Papa.
Bausch + Lomb at present has initiatives in different phases of pre-medical and medical development, together with new in excess of-the-counter eye treatment products, get hold of lenses, innovative software and prescription prescription drugs for myopia management, subsequent-technology cataract and LASIK surgical gear, premium intraocular lenses, investigational treatment options for dry eye and preservative-totally free formulations of a selection of eye drops.
Solid, Skilled Leaders Chosen for Board of Directors and Executive Management Staff
The Bausch + Lomb Board of Administrators, which features the subsequent people today, has a equilibrium of sturdy organization and health and fitness treatment encounter:
- Joseph C. Papa, Chairman
- Thomas W. Ross, Sr., Direct Unbiased Director
- Nathalie Bernier
- Richard U. DeSchutter
- Sarah B. Kavanagh
- John A. Paulson
- Russel C. Robertson
- Andrew C. von Eschenbach, M.D.
The Bausch + Lomb government management group involves:
- Joseph C. Papa, Chairman and CEO
- Christina Ackermann, Executive Vice President & Basic Counsel, and President, Ophthalmic Pharmaceuticals
- Dennis Asharin, Government Vice President, Chief World wide Producing and Provide Chain Officer
- Sam Eldessouky, Main Economical Officer
- Joseph (Joe) Gordon, President, World-wide Consumer, Surgical and Eyesight Treatment
- Yehia Hashad, M.D., Executive Vice President of Research & Improvement and Main Professional medical Officer
- Louis Yu, Ph.D., Government Vice President, Main Quality Officer
- Kelly Webber, Executive Vice President, Chief Human Resources Officer